Iisipin mo bang si Michael Jackson, na kumita nang milyong dolyar, ay mama-matay na mahirap at baon pa sa utang?
Nakakagulat ‘di ba?
Nakatira siya sa isang malaki at mala-palasyong bahay at magsisimula ulit ng concert tour sa 50 shows sa buong United Kingdom para maiahon niya ang sarili sa mga pagkakautang.
Parang kuwentong kutsero pero ang totoo, umaabot ang pagkakautang ni Michael Jackson nang mahigit US$400 million.
Ang sinasabing mga magaganda niyang investments, tulad ng catalogue ng mga kanta ng Beatles nina Paul McCartney at John Lennon ay naibenta na pala niya noong nabubuhay pa ang King of Pop.
Mayroon din siyang rights sa ibang kanta ni Elvis Presley pero hindi natin alam kung nasa kanya pa ang mga ito.
Marami tuloy ang nagtatanong kung papaano na ang kanyang tatlong anak?
Kanino mapupunta ang mga ito at ano na ang naghihintay na kinabukasan sa kanila?
Maraming misteryong lumabas nang mamatay si Michael at muling naungkat ang kaso niyang child abuse at kung paanong ang mala-king bahagi ng kanyang kayamanan ay nawala para iba-yad sa magulang ng batang unang nagreklamo sa kanya.
Malaking pera rin ang nagamit umano para ayusin ang iba pang balak magdemanda sa singer at hindi na umabot sa korte para maiwasan ang bad publicity.
May nagsasabi ring mas malaki ang kanyang ginagastos kaysa sa kanyang kinikita kaya nabaon na rin siya nang todo sa utang.
Ito ang mas nakalulungkot na kuwento sa pagkamatay ni Michael Jackson.
The mortality and morbidity associated with the use on non-steroidal anti-inflammatory drugs (NSAIDs) is a growing concern. Medical experts and research studies, after all, have proven that majority of NSAIDs have the propensity to cause upper gastro-intestinal (GI) side effects such as dyspepsia, peptic ulcer, hemorrhage and perforation.
NSAIDs likewise contribute to the management of arthritis and other inflammatory conditions. Several studies show that ulcers are documented endoscopically in up to 40% of chronic NSAID users, hence the need for concomitantly prescribing Gastroprotective agents with NSAIDs.
Based on a randomized, multicenter, controlled trial, (STORM Study) Rebamipide prevented peptic ulcers as effectively as Misoprostol in patients on long-term NSAID therapy. In addition, Rebamipide showed fewer abdominal symptoms more significantly than Misoprostol, thus proving its safety and efficacy.
Rebamipide (Mucosta) was launched March 2003 and is now considered as the leading cytoprotective agent in the Philippines. Initially indicated for gastritis and gastric ulcer, it has recently been approved by BFAD for the prevention of NSAID induced gastropathy last December 2008.
Otsuka (Philippines) Pharmaceutical, Inc., headed by Mucosta product manager, Mr. Joel Almariego, recently held a new indication product launch for Rebamipide (Mucosta) for the prevention of NSAID induced gastropathy
President and GM Mr. Leopoldo Dimerin gave the opening remarks and GI experts, Drs. Melchor Chan and Frederik Dy gave a lecture on NSAID induced gastropathy and the STORM study and the role of Rebamipide for NSAID induced gastropathy, respectively.
Nakakagulat ‘di ba?
Nakatira siya sa isang malaki at mala-palasyong bahay at magsisimula ulit ng concert tour sa 50 shows sa buong United Kingdom para maiahon niya ang sarili sa mga pagkakautang.
Parang kuwentong kutsero pero ang totoo, umaabot ang pagkakautang ni Michael Jackson nang mahigit US$400 million.
Ang sinasabing mga magaganda niyang investments, tulad ng catalogue ng mga kanta ng Beatles nina Paul McCartney at John Lennon ay naibenta na pala niya noong nabubuhay pa ang King of Pop.
Mayroon din siyang rights sa ibang kanta ni Elvis Presley pero hindi natin alam kung nasa kanya pa ang mga ito.
Marami tuloy ang nagtatanong kung papaano na ang kanyang tatlong anak?
Kanino mapupunta ang mga ito at ano na ang naghihintay na kinabukasan sa kanila?
Maraming misteryong lumabas nang mamatay si Michael at muling naungkat ang kaso niyang child abuse at kung paanong ang mala-king bahagi ng kanyang kayamanan ay nawala para iba-yad sa magulang ng batang unang nagreklamo sa kanya.
Malaking pera rin ang nagamit umano para ayusin ang iba pang balak magdemanda sa singer at hindi na umabot sa korte para maiwasan ang bad publicity.
May nagsasabi ring mas malaki ang kanyang ginagastos kaysa sa kanyang kinikita kaya nabaon na rin siya nang todo sa utang.
Ito ang mas nakalulungkot na kuwento sa pagkamatay ni Michael Jackson.
The mortality and morbidity associated with the use on non-steroidal anti-inflammatory drugs (NSAIDs) is a growing concern. Medical experts and research studies, after all, have proven that majority of NSAIDs have the propensity to cause upper gastro-intestinal (GI) side effects such as dyspepsia, peptic ulcer, hemorrhage and perforation.
NSAIDs likewise contribute to the management of arthritis and other inflammatory conditions. Several studies show that ulcers are documented endoscopically in up to 40% of chronic NSAID users, hence the need for concomitantly prescribing Gastroprotective agents with NSAIDs.
Based on a randomized, multicenter, controlled trial, (STORM Study) Rebamipide prevented peptic ulcers as effectively as Misoprostol in patients on long-term NSAID therapy. In addition, Rebamipide showed fewer abdominal symptoms more significantly than Misoprostol, thus proving its safety and efficacy.
Rebamipide (Mucosta) was launched March 2003 and is now considered as the leading cytoprotective agent in the Philippines. Initially indicated for gastritis and gastric ulcer, it has recently been approved by BFAD for the prevention of NSAID induced gastropathy last December 2008.
Otsuka (Philippines) Pharmaceutical, Inc., headed by Mucosta product manager, Mr. Joel Almariego, recently held a new indication product launch for Rebamipide (Mucosta) for the prevention of NSAID induced gastropathy
President and GM Mr. Leopoldo Dimerin gave the opening remarks and GI experts, Drs. Melchor Chan and Frederik Dy gave a lecture on NSAID induced gastropathy and the STORM study and the role of Rebamipide for NSAID induced gastropathy, respectively.
